About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Venlafaxine
- Procedure number
- PSUSA/00003104/202205
- Regulatory outcome
- Variation
Documents
Venlafaxine : List of nationally authorised medicinal products - PSUSA/00003104/202205
English (EN) (948.12 KB - PDF)
Venlafaxine : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00003104/202205
English (EN) (34.55 KB - PDF)
български (BG) (210.27 KB - PDF)
español (ES) (106.31 KB - PDF)
čeština (CS) (136.62 KB - PDF)
dansk (DA) (105.94 KB - PDF)
Deutsch (DE) (110.09 KB - PDF)
eesti keel (ET) (104.85 KB - PDF)
ελληνικά (EL) (126.63 KB - PDF)
français (FR) (109.26 KB - PDF)
hrvatski (HR) (119.76 KB - PDF)
íslenska (IS) (105.37 KB - PDF)
italiano (IT) (107.3 KB - PDF)
latviešu valoda (LV) (146.5 KB - PDF)
lietuvių kalba (LT) (144.81 KB - PDF)
magyar (HU) (140.57 KB - PDF)
Malti (MT) (147.59 KB - PDF)
Nederlands (NL) (111 KB - PDF)
norsk (NO) (105.23 KB - PDF)
polski (PL) (143.22 KB - PDF)
português (PT) (107.04 KB - PDF)
română (RO) (143.34 KB - PDF)
slovenčina (SK) (128.91 KB - PDF)
slovenščina (SL) (125.7 KB - PDF)
Suomi (FI) (87.01 KB - PDF)
svenska (SV) (103.78 KB - PDF)